Diphenoxylate and Atropine |
Logen; Lomotil; Lonox |
Lomotil is the trade name of a popular oral anti-diarrheal drug in the United States, manufactured by Pfizer. Its active ingredients are diphenoxylate and atropine. Diphenoxylate is anti-diarrheal and atropine is anticholinergic. Diphenoxylate is chemically related to the narcotic drug meperidine. Atropine is used to treat diarrhea that is not caused by infection with bacteria. The medication works by slowing down the movement of the intestines. The inactive ingredients of Lomotil are cherry ...
Wikipedia - [full article]
Diphenoxylate and Atropine Clinical Trials
- Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years Old
ClinicalTrials.gov Identifier: NCT00315302 - Active, not recruiting
Amblyopia
- Trial Comparing Daily Atropine versus Weekend Atropine
ClinicalTrials.gov Identifier: NCT00094614 - Completed
Amblyopia
- Analysis of Atropine and Propranolol Induced Changes
ClinicalTrials.gov Identifier: NCT00251602 - Active, not recruiting
Healthy
- Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds
ClinicalTrials.gov Identifier: NCT00315328 - Active, not recruiting
Amblyopia
- Amblyopia Treatment Study (ATS)
ClinicalTrials.gov Identifier: NCT00000170 - Active, not recruiting
Amblyopia
- Measurement of Stress During Anesthesia With ”Pain Detector” on Patients Receiving Atropine
ClinicalTrials.gov Identifier: NCT00328900 - Recruiting
Hemorrhoids; Fissure in Ano
- Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy
ClinicalTrials.gov Identifier: NCT00575523 - Recruiting
Arrhythmia; Respiratory Arrest
- Study of Myopia Prevention in Children With Low Concentration of Atropine
ClinicalTrials.gov Identifier: NCT00541177 - Recruiting
Myopia
- Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In Children
ClinicalTrials.gov Identifier: NCT00371124 - Recruiting
Myopia
- Daily Patching Plus Daily Atropine for Residual Amblyopia in Children 3 to <8 Years Old
ClinicalTrials.gov Identifier: NCT00506675 - Recruiting
Amblyopia
- Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops
ClinicalTrials.gov Identifier: NCT00457717 - Completed
Myopia
- An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old
ClinicalTrials.gov Identifier: NCT00094692 - Completed
Amblyopia
Resources
- Diphenoxylate and Atropine (Drug Digest)
- Logen (Drug Digest)

Not Signed In -

